Athira Pharma, Inc.
Industry: Life Sciences ・ $ATHA on Nasdaq
Insider Sale
+$3,515
-1.42%
Shares
Shares Volume: 1,208 Shares
Average Share Price: $2.91
INSIDER
Gengos Andrew
CFO AND CHIEF BUSINESS OFFICER (Officer)
reported on Feb 16 2024
traded on Jan 4 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 83,804 |
| PURCHASES/SALES 1Y | 2 / 2 |
| P/S VALUE RATIO | 34.44 |
| AVERAGE SALE VALUE | $3,515.28 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 5 / 7 |
| P/S VALUE RATIO | 35.61 |
| AVERAGE SALE VALUE | $7,018.92 |
| COMPANY PREVIOUS TRADES |